| Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in … T Haferlach, A Kohlmann, L Wieczorek, G Basso, GT Kronnie, MC Béné, ... Journal of clinical oncology 28 (15), 2529-2537, 2010 | 716 | 2010 |
| Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia T Schenk, WC Chen, S Göllner, L Howell, L Jin, K Hebestreit, HU Klein, ... Nature medicine 18 (4), 605-611, 2012 | 701 | 2012 |
| Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936 PAS Evans, C Pott, P Groenen, G Salles, F Davi, F Berger, JF Garcia, ... Leukemia 21 (2), 207-214, 2007 | 355 | 2007 |
| Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia RE Gale, R Hills, AR Pizzey, PD Kottaridis, D Swirsky, AF Gilkes, ... Blood 106 (12), 3768-3776, 2005 | 229 | 2005 |
| CD200 as a prognostic factor in acute myeloid leukaemia A Tonks, R Hills, P White, B Rosie, KI Mills, AK Burnett, RL Darley Leukemia 21 (3), 566-568, 2007 | 224 | 2007 |
| An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study … A Kohlmann, TJ Kipps, LZ Rassenti, JR Downing, SA Shurtleff, KI Mills, ... British journal of haematology 142 (5), 802-807, 2008 | 218 | 2008 |
| The dielectrophoresis enrichment of CD34+ cells from peripheral blood stem cell harvests. M Stephens, MS Talary, R Pethig, AK Burnett, KI Mills Bone marrow transplantation 18 (4), 777-782, 1996 | 213 | 1996 |
| Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome KI Mills, A Kohlmann, PM Williams, L Wieczorek, W Liu, R Li, W Wei, ... Blood, The Journal of the American Society of Hematology 114 (5), 1063-1072, 2009 | 203 | 2009 |
| Dielectrophoretic separation and enrichment of CD34+ cell subpopulation from bone marrow and peripheral blood stem cells MS Talary, KI Mills, T Hoy, AK Burnett, R Pethig Medical and Biological Engineering and Computing 33, 235-237, 1995 | 157 | 1995 |
| Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia MT Dorak, T Lawson, HKG Machulla, C Darke, KI Mills, AK Burnett Blood, The Journal of the American Society of Hematology 94 (2), 694-700, 1999 | 154 | 1999 |
| The effects of lestaurtinib (CEP701) and PKC412 on primary AML blasts: the induction of cytotoxicity varies with dependence on FLT3 signaling in both FLT3-mutated and wild-type … S Knapper, KI Mills, AF Gilkes, SJ Austin, V Walsh, AK Burnett Blood 108 (10), 3494-3503, 2006 | 152 | 2006 |
| Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes H Dolatshad, A Pellagatti, FG Liberante, M Llorian, E Repapi, V Steeples, ... Leukemia 30 (12), 2322-2331, 2016 | 137 | 2016 |
| Validation of next generation sequencing technologies in comparison to current diagnostic gold standards for BRAF, EGFR and KRAS mutational analysis CM McCourt, DG McArt, K Mills, MA Catherwood, P Maxwell, DJ Waugh, ... PLoS One 8 (7), e69604, 2013 | 129 | 2013 |
| The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients KI Mills, ED MacKenzie, GD Birnie Blood 72 (4), 1237-1241, 1988 | 123 | 1988 |
| Protein tyrosine phosphatase receptor type C (PTPRC or CD45) MA Al Barashdi, A Ali, MF McMullin, K Mills Journal of clinical pathology 74 (9), 548-552, 2021 | 118 | 2021 |
| Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts E Walsby, V Walsh, C Pepper, A Burnett, K Mills haematologica 93 (5), 662-669, 2008 | 111 | 2008 |
| Elevated Bcr-Abl expression levels are sufficient for a haematopoietic cell line to acquire a drug-resistant phenotype K Keeshan, KI Mills, TG Cotter, SL McKenna Leukemia 15 (12), 1823-1833, 2001 | 98 | 2001 |
| Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia A Tonks, L Pearn, M Musson, A Gilkes, KI Mills, AK Burnett, RL Darley Leukemia 21 (12), 2495-2505, 2007 | 97 | 2007 |
| Amplification of mitochondrial DNA in acute myeloid leukaemia J Boultwood, C Fidler, KI Mills, PM Frodsham, R Kusec, A Gaiger, ... British journal of haematology 95 (2), 426-431, 1996 | 95 | 1996 |
| Does the breakpoint within the major breakpoint cluster region (M-bcr) influence the duration of the chronic phase in chronic myeloid leukemia? An analytical comparison of … KI Mills, P Benn, GD Birnie Blood 78 (5), 1155-61, 1991 | 88 | 1991 |
